| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 医药(元) | - | - | - | - | 5,917,926,806.82 |
| 医药主营业务(元) | 5,422,698,599.77 | 11,956,513,829.18 | 6,411,516,229.06 | 11,440,239,653.78 | - |
| 营业成本(元) | |||||
| 医药(元) | - | - | - | - | 4,340,070,263.76 |
| 医药主营业务(元) | 4,028,840,831.08 | 9,106,246,189.06 | 4,826,838,444.09 | 8,511,511,467.38 | - |
| 毛利(元) | |||||
| 医药(元) | - | - | - | - | 1,577,856,543.06 |
| 医药主营业务(元) | 1,393,857,768.69 | 2,850,267,640.12 | 1,584,677,784.97 | 2,928,728,186.40 | - |
| 毛利率(%) | |||||
| 医药(%) | - | - | - | - | 26.66 |
| 医药主营业务(%) | 25.70 | 23.84 | 24.72 | 25.60 | - |
| 收入构成(%) | |||||
| 医药(%) | - | - | - | - | 100.00 |
| 医药主营业务(%) | 100.00 | 100.00 | 100.00 | 100.00 | - |
| 毛利构成(%) | |||||
| 医药(%) | - | - | - | - | 100.00 |
| 医药主营业务(%) | 100.00 | 100.00 | 100.00 | 100.00 | - |